WordNet
- the 20th letter of the Roman alphabet (同)t
PrepTutorEJDIC
- tritiumの化学記号
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 孤立性左室心筋緻密化障害 isolated left ventricular noncompaction
- 2. 有機酸血症 organic acidemias
English Journal
- Comparison between piperacillin/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: A prospective, randomized study.
- Sano H1, Kobayashi R, Suzuki D, Kishimoto K, Yasuda K, Kobayashi K.
- Pediatric blood & cancer.Pediatr Blood Cancer.2014 Sep 22. doi: 10.1002/pbc.25178. [Epub ahead of print]
- To evaluate the efficacy and safety of piperacillin/tazobactam (PIPC/TAZ) or cefepime (CFPM) monotherapy for febrile neutropenia (FN) in children, a total of 53 patients with 213 febrile episodes were randomly treated with either PIPC/TAZ 337.5 mg/kg/day, or CFPM 100 mg/kg/day. No significant di
- PMID 25251104
- Nephrotoxicity induced by piperacillin–tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia.
- Karino F1, Nishimura N, Ishihara N, Moriyama H, Miura K, Hamaguchi S, Sutani A, Kuraki T, Ikawa K, Morikawa N.
- Biological & pharmaceutical bulletin.Biol Pharm Bull.2014;37(12):1971-6.
- This study aimed to clarify the efficacy, safety, and pharmacokinetics of piperacillin–tazobactam (PIPC– TAZ) in late elderly Japanese patients. This is the first antimicrobial pilot study in late elderly patients with nursing and healthcare associated pneumonia. After PIPC–TAZ administration,
- PMID 25590089
- Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan.
- Yamamoto Y1, Izumikawa K, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Yanagihara K, Yasuoka A, Kohno S.
- Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.J Infect Chemother.2013 Apr;19(2):291-8. doi: 10.1007/s10156-013-0552-6. Epub 2013 Jan 24.
- Healthcare-associated pneumonia (HCAP) may have a more severe course than community-acquired pneumonia (CAP); hence, it is more likely to be caused by drug-resistant bacterial pathogens and anaerobes involved in aspiration pneumonia. We compared the efficacy and safety of initial empiric therapy wit
- PMID 23345050
Japanese Journal
- Nephrotoxicity induced by piperacillin-tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia
- Karino Fumi,Nishimura Nobuhiho,Ishihara Noriyuki,Moriyama Hidehiko,Miura Kiyotaka,Hamaguchi Shunichi,Sutani Akihisa,Kuraki Takashige,Ikawa Kazuro,Morikawa Norifumi,Naora Kohji,Isobe Takeshi
- Biological and Pharmaceutical Bulletin, 2014
- … This study aimed to clarify the efficacy, safety, and pharmacokinetics of piperacillin-tazobactam (PIPC-TAZ) in late elderly Japanese patients. … After PIPC-TAZ administration, PIPC concentrations in plasma were measured chromatographically and the pharmacokinetic parameters were estimated. … Serious nephrotoxicity was observed in 4 cases (18.2%) after administration of PIPC-TAZ. …
- NAID 130004693807
- 日-P2-182 PK-PD理論に基づいたPIPC-TAZ投与が高齢者の臨床検査値へ及ぼす影響(感染制御(治療薬),ポスター発表,一般演題,再興、再考、創ろう最高の医療の未来)
- 藤 裕美,片山 直子,黄前 尚樹,角山 香織,桑原 晶子,山森 元博,三浦 誠,栄田 敏之
- 日本医療薬学会年会講演要旨集 23, 382, 2013-08-28
- NAID 110009797040
- Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan
- Yamamoto Yoshihiro,Izumikawa Koichi,Morinaga Yoshitomo,Nakamura Shigeki,Kurihara Shintaro,Imamura Yoshifumi,Miyazaki Taiga,Tsukamoto Misuzu,Kakeya Hiroshi,Yanagihara Katsunori,Yasuoka Akira,Kohno Shigeru
- Journal of Infection and Chemotherapy 19(2), 291-298, 2013-04
- … We compared the efficacy and safety of initial empiric therapy with piperacillin/tazobactam (PIPC/TAZ, 13.5 g/day) with that of meropenem (MEPM, 1.5 g/day) as single broad-spectrum regimens with gram-negative and anaerobic coverage in patients with HCAP in Japan. … The clinical cure rate was 75.9 % (22/29 cases) in the PIPC/TAZ group and 64.3 % (18/28 cases) in the MEPM group. …
- NAID 120005323724
Related Links
- プレボテラ属（プレボテラ・ビビアを除く）(TAZ配合以前のPIPCが元々抗菌力を有するため) 6. 用法・用量 敗血症及び肺炎の場合 通常、成人にはタゾバクタムナトリウム・ピペラシリンナトリウムとして、1回4.5g（力価）を1日3回点滴静注 ...
- HOME > 新薬・新製品情報 > TAZとPIPC配合、抗菌薬「ゾシン」を発売 大正富山医薬品 « 前の記事 次の記事 » 前ページへ戻る » 新着記事一覧 » 全カテゴリー一覧 » 関連キーワードで記事検索: 大正富山医薬品 大鵬薬品 ワイス 感 ...
Related Pictures
★リンクテーブル★
| 関連記事 | 「TA」「PI」「PIP」「T」「PIPC」 |
「TA」
- 総動脈管 truncus artenosus
- 血小板無力症 thrombasthenia = グランツマン血小板無力症 = Glanzmann thrombasthenia
- 三尖弁閉鎖症 tricuspid atresia
- 高安動脈炎 Takayasu arteritis、高安病 Takayasu's disease Takayasu disease =大動脈炎症候群 aortitis syndrome、脈なし病
「PI」
- 肺動脈弁閉鎖不全症 pulmonary insufficiency
- ホスファチジルイノシトール phosphatidyl inositol PtdIns
- ホスホイノシチド
- 肺梗塞 pulmonary infarction
「PIP」
「T」